1. Home
  2. SPCE vs GBIO Comparison

SPCE vs GBIO Comparison

Compare SPCE & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$3.20

Market Cap

207.3M

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.77

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
GBIO
Founded
2017
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.3M
36.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SPCE
GBIO
Price
$3.20
$5.77
Analyst Decision
Hold
Buy
Analyst Count
6
5
Target Price
$9.22
$8.88
AVG Volume (30 Days)
6.0M
65.1K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,661,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2,656.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$3.00
52 Week High
$6.74
$12.40

Technical Indicators

Market Signals
Indicator
SPCE
GBIO
Relative Strength Index (RSI) 42.58 60.89
Support Level $3.08 $5.40
Resistance Level $3.33 $5.69
Average True Range (ATR) 0.27 0.22
MACD -0.03 0.04
Stochastic Oscillator 23.66 87.72

Price Performance

Historical Comparison
SPCE
GBIO

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: